Search:
Home  About  Submit Site    
  
 
Bosentan (under the brand name Tracleer by Actelion Pharmaceuticals) is the first approved endothelian receptor antagonist. It was approved by the FDA in November 2001 and is used in the treatment of Pulmonary Arterial Hypertension.
This directory is made available through a Creative Commons Attribution license from the DMOZ Organization.

© 2025 - Midnight Design Productions, LLC